MedPath

Ayurveda Management of ADHD in childre

Phase 2
Conditions
Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type
Registration Number
CTRI/2023/08/055951
Lead Sponsor
Dr Shravani K S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children those who are wishing to participate with the consent of parents will be

included.

Children diagnosed with ADHD aged between 2-16years irrespective of gender,

religion, socioeconomical status will be included for the present study.

Exclusion Criteria

ADHD in children associated with other behavioural disorders like autism spectrum

disorder, intellectual disability, learning disability, seizures and other systemic

disorders will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
assessment of inattention, hyperactivity, impulsivityTimepoint: assessment done before treatment (1st day), after treatment (30th day), after follow up (60th day)
Secondary Outcome Measures
NameTimeMethod
assessment of HyperactivityTimepoint: assessed on 1st day, 30th day, 60th day
© Copyright 2025. All Rights Reserved by MedPath